Lisa Carron Shmerling
Geen lopende functies
Profiel
Lisa Carron Shmerling has been Vice President-Legal Affairs of Momenta Pharmaceuticals, Inc. since March 2006.
From April 2005 to February 2006, she was Deputy General Counsel of Momenta Pharmaceuticals and a Legal Consultant from September 2003 to March 2005.
From 1998 to 2003, Ms. Shmerling was an Associate General Counsel of Millennium Pharmaceuticals, Inc. She received a BSW degree from The State University of New York and a JD from the New England School of Law.
Eerdere bekende functies van Lisa Carron Shmerling
| Bedrijven | Functie | Einde |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Algemeen Adviseur | 01-01-2003 |
| MOMENTA PHARMACEUTICALS, INC. | Algemeen Adviseur | - |
Opleiding van Lisa Carron Shmerling
| State University of New York at Albany | Undergraduate Degree |
| Southern New England School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
